Literature DB >> 32863769

Correction to: Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.

Chia-Chen Hsu1, Yu-Fu Su1,2, Kuo-Yang Tsai3,4, Feng-Chih Kuo5, Chi-Fu Chiang6, Chu-Yen Chien1, Ying-Chen Chen7, Chien-Hsing Lee5, Yu-Chiao Wu6, Kun Wang8, Shyun-Yeu Liu9, Yi-Shing Shieh6,10.   

Abstract

[This corrects the article DOI: 10.1186/s12935-020-01401-w.].
© The Author(s) 2020.

Entities:  

Year:  2020        PMID： 32863769      PMCID： PMC7448332          DOI： 10.1186/s12935-020-01478-3

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN： 1475-2867            Impact factor:   5.722


Correction to: Cancer Cell Int (2020) 20:300 10.1186/s12935-020-01401-w

Following publication of the original article [1] the authors have notified us of an error in Fig. 5. The incorrect vs. correct Fig. 5 are presented below: Original Figure: Correct Figure:
  1 in total

1.  Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.

Authors:  Chia-Chen Hsu; Yu-Fu Su; Kuo-Yang Tsai; Feng-Chih Kuo; Chi-Fu Chiang; Chu-Yen Chien; Ying-Chen Chen; Chien-Hsing Lee; Yu-Chiao Wu; Kun Wang; Shyun-Yeu Liu; Yi-Shing Shieh
Journal:  Cancer Cell Int       Date:  2020-07-10       Impact factor: 5.722
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.